Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

(Κλικ: 143;προσθήκη ιστοσελίδας: Jun 26, 2015)

Περιγραφή:

Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.